KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Taxes: 2018-2024

Historic Current Taxes for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $176,000.

  • Adaptive Biotechnologies' Current Taxes rose 198.31% to $176,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $176,000, marking a year-over-year increase of 198.31%. This contributed to the annual value of $176,000 for FY2024, which is 198.31% up from last year.
  • As of FY2024, Adaptive Biotechnologies' Current Taxes stood at $176,000, which was up 198.31% from $59,000 recorded in FY2023.
  • Adaptive Biotechnologies' 5-year Current Taxes high stood at $1.8 million for FY2020, and its period low was $59,000 during FY2023.
  • Moreover, its 3-year median value for Current Taxes was $176,000 (2024), whereas its average is $143,000.
  • Per our database at Business Quant, Adaptive Biotechnologies' Current Taxes plummeted by 77.87% in 2021 and then skyrocketed by 198.31% in 2024.
  • Yearly analysis of 5 years shows Adaptive Biotechnologies' Current Taxes stood at $1.8 million in 2020, then tumbled by 77.87% to $391,000 in 2021, then slumped by 50.38% to $194,000 in 2022, then crashed by 69.59% to $59,000 in 2023, then surged by 198.31% to $176,000 in 2024.